Dyslipidemia Is Associated With Asthma Exacerbations and Uncontrolled Asthma
Colby Stong Dyslipidemia is a risk factor for uncontrolled asthma and is an independent risk factor for future asthma exacerbations, according to study findings published in Journal of Allergy and Clinical Immunology: In Practice. Long-term studies of the relationship between dyslipidemia, asthma phenotypes, and future asthma exacerbations (AEs) are scarce, and the underlying mechanisms linking asthma […]
Probiotic Supplements Linked to Improved QoL, Pulmonary Function in Asthma
Sheila Jacobs Use of probiotic supplementation in patients with asthma has been associated with improved pulmonary function and quality-of-life parameters, according to study findings published in the journal Allergy, Asthma & Clinical Immunology. The investigators sought to explore how probiotic supplementation of patients with asthma affected their clinical asthma symptoms, the expression pattern of selective microRNAs […]
Adults With Asthma Have Increased Risk for Post-COVID-19 Respiratory Symptoms
Ron Goldberg Patients with asthma had higher risk for cough, bronchospasm, shortness of breath, and wheezing vs those without asthma history post-acute COVID-19. Adult patients with asthma may have an under-realized risk of respiratory symptoms and incident symptom development up to 6 months post-COVID-19 infection, according to study findings published in The Journal of Allergy and […]
Decoding the genetic and epigenetic basis of asthma
Bernard S. Stikker, Rudi W. Hendriks, Ralph Stadhouders Allergy. Accepted Author Manuscript. https://doi.org/10.1111/all.15666 Abstract Asthma is a complex and heterogeneous chronic inflammatory disease of the airways. Alongside environmental factors, asthma susceptibility is strongly influenced by genetics. Given its high prevalence and our incomplete understanding of the mechanisms underlying disease susceptibility, asthma is frequently studied in genome-wide association studies […]
Omalizumab Reduces Exacerbations in Allergic Bronchopulmonary Aspergillosis
Colby Stong Omalizumab resulted in significantly lowered OCS use in 65% of patients with ABPA and eliminated OCS use in 53% of patients. Omalizumab was associated with a significant decrease in the annual exacerbation rate and use of oral corticosteroids (OCS) in patients with allergic bronchopulmonary aspergillosis (ABPA), according to meta-analysis findings in the Journal of […]
New for Journal of Asthma online now on Taylor & Francis Online:
Research Article Does the severity of asthma affect exercise capacity and daily physical activity?Rocco Francesco Rinaldo MD, Gianluca Imeri MD, Michele Mondoni MD, Elena Maria Parazzini MD, Beatrice Vigo MD, Alessandra Masseroni MD, Stefano Centanni MD, PhD & Fabiano Di Marco MD, PhDPages: 1-10 | DOI: 10.1080/02770903.2023.2169932 Evaluating the effect and user satisfaction of an […]
Short Sleep Duration Is Risk Factor for Poorly Controlled Asthma
Short sleep duration was significantly associated with poorly controlled asthma, significant airway inflammation, and lower IgE levels. Patients with asthma and a short sleep duration have a significantly increased risk for poorly controlled asthma and moderate-to-severe asthma exacerbations (AEs), researchers reported in the Journal of Allergy and Clinical Immunology: In Practice. Investigators sought to explore the […]
Men With Asthma and Those Taking ICS-LABA Have Greater Risk in COVID-19
Ron Goldberg At 12 months after acute COVID-19 infection, 30% of patients with asthma had dyspnea and 12% had chest pain and/or cough. Patients with asthma who develop COVID-19 are at increased risk for hospitalization if they are male, currently smoke, and/or take inhaled corticosteroids (ICS) with long-acting beta-agonists (LABA), according to study findings published […]
Intermittent Oral Corticosteroid Asthma Prescriptions Linked to Adverse Outcomes
Ron Goldberg Sleep apnea and pneumonia were the most commonly experienced AOs in patients with asthma who received increasingly frequent OCS prescriptions. Patients who are prescribed intermittent oral corticosteroids (OCS) for asthma with increasing frequency have a higher risk of OCS-related adverse outcomes (AO), according to study findings published in Thorax. Investigators sought to evaluate the […]
Nasal TSLP and periostin in infants with severe bronchiolitis and risk of asthma at 4 years of age
Research – Open Access Maria Luz Garcia-Garcia, Beatriz Sastre, Maria Arroyas, Maite Beato, Patricia Alonso, José Manuel Rodrigo-Muñoz, Victoria Del Pozo, Inmaculada Casas & Cristina Calvo Respiratory Research volume 24, Article number: 26 (2023) Abstract Background Severe bronchiolitis is often associated with subsequent respiratory morbidity, mainly recurrent wheezing and asthma. However, the underlying immune mechanisms remain unclear. The main goal of this study was to investigate the association of […]